302 related articles for article (PubMed ID: 27790783)
1. Pharmacogenomics of inhaled corticosteroids and leukotriene modifiers: a systematic review.
Farzan N; Vijverberg SJ; Arets HG; Raaijmakers JA; Maitland-van der Zee AH
Clin Exp Allergy; 2017 Feb; 47(2):271-293. PubMed ID: 27790783
[TBL] [Abstract][Full Text] [Related]
2. Review on Pharmacogenetics and Pharmacogenomics Applied to the Study of Asthma.
Sánchez-Martín A; García-Sánchez A; Isidoro-García M
Methods Mol Biol; 2016; 1434():255-72. PubMed ID: 27300544
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics of Leukotriene Modifiers: A Systematic Review and Meta-Analysis.
Zhao Y; Zhang X; Han C; Cai Y; Li S; Hu X; Wu C; Guan X; Lu C; Nie X
J Pers Med; 2022 Jun; 12(7):. PubMed ID: 35887565
[TBL] [Abstract][Full Text] [Related]
4. Treatment response heterogeneity in asthma: the role of genetic variation.
Vijverberg SJH; Farzan N; Slob EMA; Neerincx AH; Maitland-van der Zee AH
Expert Rev Respir Med; 2018 Jan; 12(1):55-65. PubMed ID: 29115880
[TBL] [Abstract][Full Text] [Related]
5. FCER2 T2206C variant associated with chronic symptoms and exacerbations in steroid-treated asthmatic children.
Koster ES; Maitland-van der Zee AH; Tavendale R; Mukhopadhyay S; Vijverberg SJ; Raaijmakers JA; Palmer CN
Allergy; 2011 Dec; 66(12):1546-52. PubMed ID: 21958076
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics of inhaled corticosteroids and exacerbation risk in adults with asthma.
Edris A; de Roos EW; McGeachie MJ; Verhamme KMC; Brusselle GG; Tantisira KG; Iribarren C; Lu M; Wu AC; Stricker BH; Lahousse L
Clin Exp Allergy; 2022 Jan; 52(1):33-45. PubMed ID: 33428814
[TBL] [Abstract][Full Text] [Related]
7. How pharmacogenomics will play a role in the management of asthma.
Wechsler ME; Israel E
Am J Respir Crit Care Med; 2005 Jul; 172(1):12-8. PubMed ID: 15778484
[No Abstract] [Full Text] [Related]
8. Pharmacogenetics of asthma.
Lima JJ; Blake KV; Tantisira KG; Weiss ST
Curr Opin Pulm Med; 2009 Jan; 15(1):57-62. PubMed ID: 19077707
[TBL] [Abstract][Full Text] [Related]
9. ST13 polymorphisms and their effect on exacerbations in steroid-treated asthmatic children and young adults.
Vijverberg SJ; Koster ES; Tavendale R; Leusink M; Koenderman L; Raaijmakers JA; Postma DS; Koppelman GH; Turner SW; Mukhopadhyay S; Tse SM; Tantisira KG; Hawcutt DB; Francis B; Pirmohamed M; Pino-Yanes M; Eng C; Burchard EG; Palmer CN; Maitland-van der Zee AH
Clin Exp Allergy; 2015 Jun; 45(6):1051-9. PubMed ID: 25616159
[TBL] [Abstract][Full Text] [Related]
10. FCER2: a pharmacogenetic basis for severe exacerbations in children with asthma.
Tantisira KG; Silverman ES; Mariani TJ; Xu J; Richter BG; Klanderman BJ; Litonjua AA; Lazarus R; Rosenwasser LJ; Fuhlbrigge AL; Weiss ST
J Allergy Clin Immunol; 2007 Dec; 120(6):1285-91. PubMed ID: 17980418
[TBL] [Abstract][Full Text] [Related]
11. Stepping down from inhaled corticosteroids with leukotriene inhibitors in asthma: a systematic review and meta-analysis.
Rank MA; Gionfriddo MR; Pongdee T; Volcheck GW; Li JT; Hagan CR; Erwin PJ; Hagan JB
Allergy Asthma Proc; 2015; 36(3):200-5. PubMed ID: 25976437
[TBL] [Abstract][Full Text] [Related]
12. Comparison of leukotriene receptor antagonists in addition to inhaled corticosteroid and inhaled corticosteroid alone in the treatment of adolescents and adults with bronchial asthma: a meta-analysis.
Cao Y; Wang J; Bunjhoo H; Xie M; Xu Y; Fang H
Asian Pac J Allergy Immunol; 2012 Jun; 30(2):130-8. PubMed ID: 22830292
[TBL] [Abstract][Full Text] [Related]
13. Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids.
Tantisira KG; Lake S; Silverman ES; Palmer LJ; Lazarus R; Silverman EK; Liggett SB; Gelfand EW; Rosenwasser LJ; Richter B; Israel E; Wechsler M; Gabriel S; Altshuler D; Lander E; Drazen J; Weiss ST
Hum Mol Genet; 2004 Jul; 13(13):1353-9. PubMed ID: 15128701
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide association study of inhaled corticosteroid response in admixed children with asthma.
Hernandez-Pacheco N; Farzan N; Francis B; Karimi L; Repnik K; Vijverberg SJ; Soares P; Schieck M; Gorenjak M; Forno E; Eng C; Oh SS; Pérez-Méndez L; Berce V; Tavendale R; Samedy LA; Hunstman S; Hu D; Meade K; Farber HJ; Avila PC; Serebrisky D; Thyne SM; Brigino-Buenaventura E; Rodriguez-Cintron W; Sen S; Kumar R; Lenoir M; Rodriguez-Santana JR; Celedón JC; Mukhopadhyay S; Potočnik U; Pirmohamed M; Verhamme KM; Kabesch M; Palmer CNA; Hawcutt DB; Flores C; Maitland-van der Zee AH; Burchard EG; Pino-Yanes M
Clin Exp Allergy; 2019 Jun; 49(6):789-798. PubMed ID: 30697902
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacogenomics of asthma: present and perspective].
Szalai C; Tölgyesi G; Nagy A; Falus A
Orv Hetil; 2006 Jan; 147(4):159-69. PubMed ID: 16515024
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of Treatment Response to Asthma.
Maeda T; Khurana S
Adv Exp Med Biol; 2023; 1426():143-161. PubMed ID: 37464120
[TBL] [Abstract][Full Text] [Related]
17. Inhaled corticosteroids and leukotriene modifiers in the acute treatment of asthma exacerbations.
Foresi A; Paggiaro P
Curr Opin Pulm Med; 2003 Jan; 9(1):52-6. PubMed ID: 12476085
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis.
Sin DD; Man J; Sharpe H; Gan WQ; Man SF
JAMA; 2004 Jul; 292(3):367-76. PubMed ID: 15265853
[TBL] [Abstract][Full Text] [Related]
19. The pharmacogenetics of asthma treatment.
Tantisira K; Weiss S
Curr Allergy Asthma Rep; 2009 Jan; 9(1):10-7. PubMed ID: 19063819
[TBL] [Abstract][Full Text] [Related]
20. Treatment heterogeneity in asthma: genetics of response to leukotriene modifiers.
Lima JJ
Mol Diagn Ther; 2007; 11(2):97-104. PubMed ID: 17397245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
